Skip to content

The effectiveness of Autologous Blood Injections for the treatment of mid portion Achilles tendinopathy- a double blind randomised control trial.

The medium term effectiveness of autologous blood injections as an additional treatment to an eccentric strengthening programme for mid portion Achilles tendinopathy using the Victorian Institute of Sport Assessment- Achilles (VISA-A) scale- a double blind randomised control trial.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12610000824066
Enrollment
52
Registered
2010-10-01
Start date
2010-09-25
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The primary purpose of the study is to determine whether the addition of an autologous blood injection as an adjuvant therapy provides added benefit on top of the standard Alfredson's eccentric exercise regime alone for those with mid portion Achilles tendinopathy.

Interventions

Autologous Blood Injection. 3ml of blood will be drawn from either antecubital fossa with sterile no touch technique. No local anasthetic will be used. The blood will then be injected with a sterile no touch technique around the area of maximal Achilles tendon tenderness. It will not be injected directly into the tendon. There will not be dry needling and it will not be done under ultrasound guidance. We would hope that the time between aspiration and reinjection to be under one minute. All part

Autologous Blood Injection. 3ml of blood will be drawn from either antecubital fossa with sterile no touch technique. No local anasthetic will be used. The blood will then be injected with a sterile no touch technique around the area of maximal Achilles tendon tenderness. It will not be injected directly into the tendon. There will not be dry needling and it will not be done under ultrasound guidance. We would hope that the time between aspiration and reinjection to be under one minute. All participants will have one injection, carried out two times in total, a month apart. All participants will carry out the standard Alfredson's eccentric exercise regime.

Sponsors

Professor Ngaire Kerse
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 No limit to No maximum
Healthy volunteers
No

Inclusion criteria

Inclusion criteria: patients presenting to sports medicine/physiotherapy/ general practice clinics with first presentation of mid portion Achilles tendinopathy of at least 3 months duration

Exclusion criteria

Exclusion criteria: Bilateral Achilles tendinopathy, significant coagulopathy predisposing to bleeding, previous adjuvant treatment of the Achilles tendinopathy.

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 23, 2026